or
forgot password

    • cancer clinical trials in beverly, MA

    • Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Beverly Hospital
    Beverly, Massachusetts 01915
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Beverly Hospital
    Beverly, Massachusetts 01915
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
    Research Site
    Beverly, Massachusetts
    Non-small Cell Lung Cancer, Lung Cancer
    A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
    Research Site
    Beverly, Massachusetts
    Bone Metastases in Subjects With Advanced Breast Cancer
    STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Beverly, Massachusetts
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
    Research Site
    Beverly, Massachusetts
    Melanoma
    AZD1152 in Patients With Advanced Solid Malignancies
    Research Site
    Beverly, Massachusetts
    Tumors
    An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
    Research Site
    Beverly, Massachusetts
    Thyroid Cancer
    Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients
    Research Site
    Beverly, Massachusetts
    Non Small Cell Lung Cancer, Lung Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Beverly, Massachusetts
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Beverly, Massachusetts
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
    Research Site
    Beverly, Massachusetts
    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
    Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
    Research Site
    Beverly, Massachusetts
    Cancer, GCT, Giant Cell Tumor of Bone, Benign GCT
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Beverly, Massachusetts
    Recurrent Glioblastoma
    Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients
    Research Site
    Beverly, Massachusetts
    Advanced Solid Tumors
    Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
    Research Site
    Beverly, Massachusetts
    Breast Cancer, Breast Neoplasms, Breast Tumors, Cancer, Locally Recurrent and Metastatic Breast Cancer, Metastases, Metastatic Cancer, Oncology, Solid Tumors, Tumors
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Beverly, Massachusetts
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Beverly, Massachusetts
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
    Research Site
    Beverly, Massachusetts
    Advanced Solid Tumors, Advanced Recurrent Ovarian Tumors
    A Study of AMG 337 in Subjects With Advanced Solid Tumors
    Research Site
    Beverly, Massachusetts
    Advanced Malignancy, Advanced Solid Tumors, Cancer, Oncology, Oncology Patients, Tumors
    Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
    Research Site
    Beverly, Massachusetts
    Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
    Research Site
    Beverly, Massachusetts
    Hormone Receptor Positive Breast Cancer
    Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
    Research Site
    Beverly, Massachusetts
    N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
    Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment
    Research Site
    Beverly, Massachusetts
    Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
    Video Impact on Neulasta Education
    Research Site
    Beverly, Massachusetts
    Breast Cancer
    Iressa Expanded Access Program (EAP)
    Research Site
    Beverly, Massachusetts
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.
    Research Site
    Beverly, Massachusetts
    Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
    Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Beverly, Massachusetts
    Non-Hodgkin's Lymphoma
    AZD5438 in Patients With Advanced Solid Malignancies
    Research Site
    Beverly, Massachusetts
    Neoplasms
    PROACT - Pre-Operative Arimidex Compared To Tamoxifen
    Research Site
    Beverly, Massachusetts
    Breast Cancer
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Beverly, Massachusetts
    Refractory Melanoma
    Assessment and Tracking of Long-term Alefacept Safety
    Northeast Dermatology
    Beverly, Massachusetts 01915
    Psoriasis
    Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
    Research Site
    Beverly, Massachusetts
    Advanced Solid Tumors, Cancer, Advanced Solid Malignancies
    Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
    Research Site
    Beverly, Massachusetts
    Recurrent Glioblastoma, Brain Tumor
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Beverly, Massachusetts
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Beverly, Massachusetts
    Non-metastatic Prostate Cancer
    Oral Cladribine in Early Multiple Sclerosis (MS)
    Research Site
    Beverly, Massachusetts
    Multiple Sclerosis
    GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
    Research Site
    Beverly, Massachusetts
    Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
    A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
    Research Site
    Beverly, Massachusetts
    Glioblastoma Multiforme